Pitogo, Azrielle T.
HRN: 13-42-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/02/2022
06/09/2022
IV
397mg
Q6
Vaginal Laceration Sec To Straddle Injury
Waiting Final Action
Indication: Prophylaxis Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes